Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 1
2011 1
2016 2
2017 1
2018 1
2019 1
2020 1
2021 1
2022 7
2023 5
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD; SPIRIT-P1 Study Group. Mease PJ, et al. Ann Rheum Dis. 2017 Jan;76(1):79-87. doi: 10.1136/annrheumdis-2016-209709. Epub 2016 Aug 23. Ann Rheum Dis. 2017. PMID: 27553214 Free PMC article. Clinical Trial.
Celebrating Versatility: Febuxostat's Multifaceted Therapeutic Application.
Kraev KI, Geneva-Popova MG, Hristov BK, Uchikov PA, Popova-Belova SD, Kraeva MI, Basheva-Kraeva YM, Stoyanova NS, Mitkova-Hristova VT. Kraev KI, et al. Among authors: geneva popova mg. Life (Basel). 2023 Nov 11;13(11):2199. doi: 10.3390/life13112199. Life (Basel). 2023. PMID: 38004339 Free PMC article. Review.
Examining the Safety Profile of Janus Kinase (JAK) Inhibitors in the Management of Immune-Mediated Diseases: A Comprehensive Review.
Kraev K, Geneva-Popova MG, Hristov BK, Uchikov PA, Belova-Popova SD, Kraeva MI, Basheva-Kraeva YM, Stoyanova NS, Mitkova-Hristova VT, Koleva-Ivanova MS, Taneva DI, Ivanov AS. Kraev K, et al. Among authors: geneva popova mg. Life (Basel). 2023 Nov 22;13(12):2244. doi: 10.3390/life13122244. Life (Basel). 2023. PMID: 38137845 Free PMC article. Review.
Capillaroscopy and Immunological Profile in Systemic Sclerosis.
Lambova SN, Kurteva EK, Dzhambazova SS, Vasilev GH, Kyurkchiev DS, Geneva-Popova MG. Lambova SN, et al. Among authors: geneva popova mg. Life (Basel). 2022 Mar 29;12(4):498. doi: 10.3390/life12040498. Life (Basel). 2022. PMID: 35454989 Free PMC article.
Comprehensive Exploration of Antinuclear Antibodies (ANAs): Unveiling Clinical Significance, Associations with Cancer, and the Nuances of Differential Diagnosis in Positive ANA Patients.
Kraev K, Hristov B, Uchikov P, Kraeva M, Basheva-Kraeva Y, Valova S, Koleva-Ivanova M, Popova-Belova S, Sandeva M, Chakarov D, Geneva-Popova M. Kraev K, et al. Among authors: geneva popova m. Diagnostics (Basel). 2024 Feb 1;14(3):320. doi: 10.3390/diagnostics14030320. Diagnostics (Basel). 2024. PMID: 38337836 Free PMC article. Review.
28 results